Mathematical modelling of HIV-HCV coinfection dynamics in absence of therapy
Summary: Globally, it is estimated that of the 36.7 million people infected with human immunodeficiency virus (HIV), 6.3\% are coinfected with hepatitis C virus (HCV). Coinfection with HIV reduces the chance of HCV spontaneous clearance. In this work, we formulated and analysed a deterministic model to study the HIV and HCV coinfection dynamics in absence of therapy. Due to chronic stage of HCV infection being long, asymptomatic, and infectious, our model formulation was based on the splitting of the chronic stage into the following: before onset of cirrhosis and its complications and after onset of cirrhosis. We computed the basic reproduction numbers using the next generation matrix method. We performed numerical simulations to support the analytical results. We carried out sensitivity analysis to determine the relative importance of the different parameters influencing the HIV-HCV coinfection dynamics. The findings reveal that, in the long run, there is a substantial number of individuals coinfected with HIV and latent HCV. Therefore, HIV and latently HCV-infected individuals need to seek early treatment so as to slow down the progression of HIV to AIDS and latent HCV to advanced HCV.
- Modeling and analysis of HIV and hepatitis C co-infections
- Dynamic analysis of a mathematical model for HIV and Hepatitis C virus co-infection
- Effects of treatment, awareness and condom use in a coinfection model for HIV and HCV in MSM
- A Mathematical Model for the Dynamics of Hepatitis C
- Optimal control application to the epidemiology of HBV and HCV co-infection
- A mathematical model of treatment and vaccination interventions of pneumococcal pneumonia infection dynamics
- Determining important parameters in the spread of malaria through the sensitivity analysis of a mathematical model
- Dynamic analysis of a mathematical model for HIV and Hepatitis C virus co-infection
- Effects of treatment, awareness and condom use in a coinfection model for HIV and HCV in MSM
- scientific article; zbMATH DE number 3568468 (Why is no real title available?)
- Modeling HIV/AIDS and tuberculosis coinfection
- On the dynamics of a vaccination model with multiple transmission ways
- Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission
- The role of HIV positive immigrants and dual protection in a co-infection of malaria and HIV/AIDS
- Theoretical assessment of public health impact of imperfect prophylactic HIV-1 vaccines with therapeutic benefits
- Mathematical modeling of liver enzyme elevation in HIV mono-infection
- Effect of DAA therapy in hepatitis C treatment -- an impulsive control approach
- Modelling hepatotoxicity and antiretroviral therapeutic effect in HIV/HBV coinfection
- Modeling the effect of vaccination and treatment on the transmission dynamics of hepatitis B virus and HIV/AIDS coinfection
- HIV/AIDS-pneumonia coinfection model with treatment at each infection stage: mathematical analysis and numerical simulation
- Mathematical analysis of the role of HIV/HBV latency in hepatocytes
- Modeling and analysis of HIV and hepatitis C co-infections
- Effects of treatment, awareness and condom use in a coinfection model for HIV and HCV in MSM
- Dynamic analysis of a mathematical model for HIV and Hepatitis C virus co-infection
- Mathematical Modelling of HIV-HCV Co-infection Dynamics in Presence of HIV Therapy
This page was built for publication: Mathematical modelling of HIV-HCV coinfection dynamics in absence of therapy
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2224243)
